← back to search

Anand P. Chokkalingam

Gilead Sciences (United Kingdom) · GB
Area of research
Public Health, Environmental and Occupational Health · Hepatology
Research interest
Research interests include Acute Lymphoblastic Leukemia research, Hepatitis C virus research, Prostate Cancer Treatment and Research, and COVID-19 Clinical Research Studies.
h-index
46
citations
10,427
works
172
NIH funding
primary concept
Medicine
email

Recent publications

Increased Risk for Liver Disease in Patients With Chronic Hepatitis B Virus Infection and Low‐Level Viraemia
Alimentary Pharmacology & Therapeutics 2026cited by 2position: middledoi
Systematic Review: Incidence of Liver-Related Events in People Living With Hepatitis Delta Virus.
2025cited by 1position: contributordoi
Remdesivir for Treatment of COVID-19 Requiring Oxygen Support: A Cross-Study Comparison From 2 Large, Open-Label Studies.
2024cited by 1position: contributordoi
Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry
European Urology 2023cited by 49position: middledoi
A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry
European Urology 2022cited by 47position: middledoi
Risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis B patients receiving tenofovir disoproxil fumarate versus entecavir in the United States.
2022cited by 15position: contributordoi
Sofosbuvir and risk of estimated glomerular filtration rate decline or end-stage renal disease in patients with renal impairment.
2022cited by 10position: contributordoi
Editorial: risk of hepatocellular carcinoma with tenofovir vs entecavir-A "knock-out" is yet to be delivered-Authors' reply.
2022cited by 0position: contributordoi
Compassionate Use of Remdesivir in Children With Severe COVID-19
PEDIATRICS 2021cited by 103position: middledoi
Remdesivir Versus Standard-of-Care for Severe Coronavirus Disease 2019 Infection: An Analysis of 28-Day Mortality
Open Forum Infectious Diseases 2021cited by 45position: middledoi
Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019
Clinical Infectious Diseases 2020cited by 120position: middledoi
A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry
European Urology 2020cited by 50position: middledoi
IDDF2020-ABS-0057 Risk of incident hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) virus-infected patients treated with tenofovir disoproxil fumarate (TDF) versus entecavir (ETV): a US administrative claims analysis
Abstracts 2020cited by 1position: middledoi
Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry
JNCI Journal of the National Cancer Institute 2017cited by 88position: middledoi
Prostate Cancer Susceptibility in Men of African Ancestry at 8q24
JNCI Journal of the National Cancer Institute 2016cited by 136position: middledoi
Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation
Nature Communications 2016cited by 58position: middledoi
Two susceptibility loci identified for prostate cancer aggressiveness
Nature Communications 2015cited by 102position: middledoi
Integration of multiethnic fine-mapping and genomic annotation to prioritize candidate functional SNPs at prostate cancer susceptibility regions
Human Molecular Genetics 2015cited by 41position: middledoi
A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer
Nature Genetics 2014cited by 470position: middledoi
Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33
Human Molecular Genetics 2014cited by 107position: middledoi
High Prevalence of Screen Detected Prostate Cancer in West Africans: Implications for Racial Disparity of Prostate Cancer
The Journal of Urology 2014cited by 66position: middledoi
A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer
UCL Discovery (University College London) 2014cited by 0position: middle
Associations between genome-wide Native American ancestry, known risk alleles and B-cell ALL risk in Hispanic children
Leukemia 2013cited by 62position: middledoi
Genetic variants in ARID5B and CEBPE are childhood ALL susceptibility loci in Hispanics
Cancer Causes & Control 2013cited by 52position: firstdoi
A global DNA methylation and gene expression analysis of early human B-cell development reveals a demethylation signature and transcription factor network
Nucleic Acids Research 2012cited by 111position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 5 papers (2022–2025)Patricia A. Buffler · University of California, Berkeley3 papers (2012–2013)Laura Telep · Gilead Sciences (United States)3 papers (2020–2026)Joseph L. Wiemels · University of Southern California2 papers (2012–2013)Adam J. de Smith · University of Southern California2 papers (2012–2013)Catherine Metayer · Berkeley Public Health Division2 papers (2013–2013)Lisa F. Barcellos · Berkeley Public Health Division2 papers (2013–2013)Xiaomei Ma · Yale Cancer Center2 papers (2012–2013)W. Ray Kim · Sungkyunkwan University2 papers (2022–2022) · 2 papers (2022–2022)John K. Wiencke · Neurological Surgery2 papers (2012–2013)Andrew A. Adjei · Roswell Park Comprehensive Cancer Center1 papers (2014–2014)LV Hong · Gilead Sciences (United States)1 papers (2026–2026)Helen M. Hansen · University of California, San Francisco1 papers (2013–2013)Polly Desai · Gilead Sciences (United States)1 papers (2021–2021)Shelley Niwa · University of Illinois Chicago1 papers (2014–2014)Stuart C. Gordon · Northwestern Medicine1 papers (2020–2020)Marina E. Fomin · Galaxy Advanced Engineering (United States)1 papers (2012–2012)David Chia · Guy's and St Thomas' NHS Foundation Trust1 papers (2014–2014)John F. Flaherty · University of California, San Francisco1 papers (2020–2020)